Overview Dividends

(CTRA) Coterra Energy - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1270971039

Oil, Natural Gas, Natural Gas Liquids

CTRA EPS (Earnings per Share)

EPS Growth (3Y CAGR): -68.72%
EPS Trend (3Y Correlation): -60.4%

CTRA Revenue

Revenue Growth (3Y CAGR): -14.61%
Revenue Trend (3Y Correlation): -33.2%

Description: CTRA Coterra Energy October 16, 2025

Coterra Energy Inc. (CTRA) is an independent U.S. oil-and-gas producer focused on three core acreage packages: roughly 2.97 million net acres in the Permian Basin (West Texas & SE New Mexico), about 1.86 million net acres in the Marcellus Shale (Susquehanna County, PA), and approximately 1.81 million net acres in the Anadarko Basin (mid-continent Oklahoma). The company also operates natural-gas and salt-water gathering and disposal infrastructure in Texas and markets its gas to a broad mix of industrial, utility, and pipeline customers. Coterra was incorporated in 1989 and is headquartered in Houston, Texas.

Recent quarterly data (Q4 2023) show average production of ~200 k boe/d, with a 12 % year-over-year increase driven largely by higher Permian output. The firm generated $1.1 billion of operating cash flow and reduced net debt to $2.3 billion, reflecting a disciplined capital-allocation strategy. Key economic drivers include the ongoing recovery in oil prices (WTI ≈ $85/bbl) and the volatility of natural-gas prices (Henry Hub ≈ $2.80/MMBtu), both of which are heavily influenced by U.S. macro-policy on energy security and the pace of global LNG demand growth.

For a deeper dive into Coterra’s valuation metrics, production forecasts, and sensitivity to commodity price swings, you may find ValueRay’s analyst toolkit useful for extending your research.

CTRA Stock Overview

Market Cap in USD	18,056m
Sub-Industry	Oil & Gas Exploration & Production
IPO / Inception	1990-02-08

CTRA Stock Ratings

Growth Rating	3.65%
Fundamental	67.7%
Dividend Rating	66.5%
Return 12m vs S&P 500	-3.32%
Analyst Rating	4.31 of 5

CTRA Dividends

Dividend Yield 12m	3.37%
Yield on Cost 5y	6.84%
Annual Growth 5y	20.38%
Payout Consistency	94.6%
Payout Ratio	49.2%

CTRA Growth Ratios

Growth Correlation 3m	-28.3%
Growth Correlation 12m	-50.7%
Growth Correlation 5y	64.8%
CAGR 5y	0.31%
CAGR/Max DD 3y (Calmar Ratio)	0.01
CAGR/Mean DD 3y (Pain Ratio)	0.03
Sharpe Ratio 12m	1.68
Alpha	3.32
Beta	0.270
Volatility	25.80%
Current Volume	27211.9k
Average Volume 20d	8881.3k
Stop Loss	25 (-3.3%)
Signal	0.52

Piotroski VR‑10 (Strict, 0-10) 6.0

Net Income (1.58b TTM) > 0 and > 6% of Revenue (6% = 389.4m TTM)

FCFTA 0.13 (>2.0%) and ΔFCFTA 8.80pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 2.62% (prev 12.07%; Δ -9.45pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.14 (>3.0%) and CFO 3.46b > Net Income 1.58b (YES >=105%, WARN >=100%)

Net Debt (4.20b) to EBITDA (4.15b) ratio: 1.01 <= 3.0 (WARN <= 3.5)

Current Ratio 1.13 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (759.0m) change vs 12m ago 1.47% (target <= -2.0% for YES)

Gross Margin 34.79% (prev 34.88%; Δ -0.09pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 29.01% (prev 26.82%; Δ 2.19pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 13.21 (EBITDA TTM 4.15b / Interest Expense TTM 159.0m) >= 6 (WARN >= 3)

Altman Z'' 2.31

(A) 0.01 = (Total Current Assets 1.52b - Total Current Liabilities 1.35b) / Total Assets 23.98b

(B) 0.27 = Retained Earnings (Balance) 6.54b / Total Assets 23.98b

(D) 0.70 = Book Value of Equity 6.64b / Total Liabilities 9.43b

Total Rating: 2.31 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 67.70

1. Piotroski 6.0pt = 1.0

2. FCF Yield 14.54% = 5.0

3. FCF Margin 49.87% = 7.50

4. Debt/Equity 0.30 = 2.46

5. Debt/Ebitda 1.01 = 1.75

6. ROIC - WACC (= 3.64)% = 4.55

7. RoE 11.48% = 0.96

8. Rev. Trend -33.24% = -2.49

9. EPS Trend -60.43% = -3.02

What is the price of CTRA shares?

As of November 05, 2025, the stock is trading at USD 25.85 with a total of 27,211,900 shares traded.
Over the past week, the price has changed by +10.56%, over one month by +8.43%, over three months by +9.01% and over the past year by +15.96%.

Is Coterra Energy a good stock to buy?

Partly, yes. Based on ValueRay´s Fundamental Analyses, Coterra Energy (NYSE:CTRA) is currently (November 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 67.70 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CTRA is around 24.37 USD . This means that CTRA is currently overvalued and has a potential downside of -5.73%.

Is CTRA a buy, sell or hold?

Coterra Energy has received a consensus analysts rating of 4.31. Therefore, it is recommended to buy CTRA.

Strong Buy: 12
Buy: 10
Hold: 4
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the CTRA price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	32	23.6%
Analysts Target Price	32	23.6%
ValueRay Target Price	26.5	2.6%

CTRA Fundamental Data Overview November 04, 2025

Market Cap USD = 18.06b (18.06b USD * 1.0 USD.USD)
P/E Trailing = 11.3206
P/E Forward = 7.3692
P/S = 2.8973
P/B = 1.2137
P/EG = 44.6673
Beta = 0.27
Revenue TTM = 6.49b USD
EBIT TTM = 2.10b USD
EBITDA TTM = 4.15b USD
Long Term Debt = 4.17b USD (from longTermDebt, last quarter)
Short Term Debt = 103.0m USD (from shortTermDebt, last quarter)
Debt = 4.39b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.20b USD (from netDebt column, last quarter)
Enterprise Value = 22.25b USD (18.06b + Debt 4.39b - CCE 192.0m)
Interest Coverage Ratio = 13.21 (Ebit TTM 2.10b / Interest Expense TTM 159.0m)
FCF Yield = 14.54% (FCF TTM 3.24b / Enterprise Value 22.25b)
FCF Margin = 49.87% (FCF TTM 3.24b / Revenue TTM 6.49b)
Net Margin = 24.28% (Net Income TTM 1.58b / Revenue TTM 6.49b)
Gross Margin = 34.79% ((Revenue TTM 6.49b - Cost of Revenue TTM 4.23b) / Revenue TTM)
Gross Margin QoQ = 32.08% (prev 44.94%)
Tobins Q-Ratio = 0.93 (Enterprise Value 22.25b / Total Assets 23.98b)
Interest Expense / Debt = 1.21% (Interest Expense 53.0m / Debt 4.39b)
Taxrate = 22.34% (147.0m / 658.0m)
NOPAT = 1.63b (EBIT 2.10b * (1 - 22.34%))
Current Ratio = 1.13 (Total Current Assets 1.52b / Total Current Liabilities 1.35b)
Debt / Equity = 0.30 (Debt 4.39b / totalStockholderEquity, last quarter 14.56b)
Debt / EBITDA = 1.01 (Net Debt 4.20b / EBITDA 4.15b)
Debt / FCF = 1.30 (Net Debt 4.20b / FCF TTM 3.24b)
Total Stockholder Equity = 13.73b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.57% (Net Income 1.58b / Total Assets 23.98b)
RoE = 11.48% (Net Income TTM 1.58b / Total Stockholder Equity 13.73b)
RoCE = 11.73% (EBIT 2.10b / Capital Employed (Equity 13.73b + L.T.Debt 4.17b))
RoIC = 9.46% (NOPAT 1.63b / Invested Capital 17.25b)
WACC = 5.82% (E(18.06b)/V(22.44b) * Re(7.01%) + D(4.39b)/V(22.44b) * Rd(1.21%) * (1-Tc(0.22)))
Discount Rate = 7.01% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 33.33 | Cagr: 0.31%
[DCF Debug] Terminal Value 78.29% ; FCFE base≈2.33b ; Y1≈2.33b ; Y5≈2.47b
Fair Price DCF = 57.36 (DCF Value 43.77b / Shares Outstanding 763.1m; 5y FCF grow -0.58% → 3.0% )
EPS Correlation: -60.43 | EPS CAGR: -68.72% | SUE: -4.0 | # QB: 0
Revenue Correlation: -33.24 | Revenue CAGR: -14.61% | SUE: 0.72 | # QB: 0

Additional Sources for CTRA Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle